Target intelligence / Profile preview

Retina and anterior neural fold homeobox protein (RAX)

Target
RAX
Molecular classification
Transcription factor, Homeobox protein
01

Overview

Retina and anterior neural fold homeobox protein (RAX) is a homeobox-containing transcription factor essential for early eye development, playing a pivotal role in retinal cell fate determination, proliferation of retinal progenitor cells, and the regulation of stem cell populations within the developing optic structures. RAX is expressed very early during eye primordia formation, and mutations in this gene are associated with a spectrum of congenital ocular malformations, including anophthalmia (no eye development), microphthalmia (abnormally small eyes), and coloboma (defective closure of the optic fissure). Beyond early development, RAX interacts with other transcription factors (such as CRX and NEUROD) to guide photoreceptor cell differentiation. As a homeobox gene, it is not a classic receptor, enzyme, or drug target, and there are currently no known drugs directly targeting RAX. Its main role is as a critical developmental regulator of eye and hypothalamic structures. - Canonical names and functional annotation are supported by OMIM, UniProt, NCBI Gene, and GeneCards. - The classification as a transcription factor, biological functions, and disease roles are established in recent review articles. - No known small molecule drugs or biologics target RAX directly; it is not a druggable target in current therapeutics. - No standard biomarkers or safety/toxicity reports associated with manipulating RAX. - If the query seeks a "receptor," note that RAX is not a receptor but a transcription factor.

Other names
Retinal homeobox protein RxRAXRXRAX1MCOP3MCOPS16Retina and anterior neural fold homeoboxRetina and anterior neural fold homeobox proteinRX_HUMAN
02

Biological functions

Eye developmentRetinal cell fate specificationProliferation of retinal progenitor cellsRegulation of stem cell proliferationPhotoreceptor differentiation
03

Disease associations

Developmental eye disorders (such as anophthalmia, microphthalmia, coloboma)Congenital malformations of the retinaOther congenital ocular conditions
04

Safety considerations

Mutations can cause severe congenital eye malformations, but specific therapeutic targeting, druggability, or safety issues as a direct therapeutic target are not described in literature.

Beyond the preview

Go deeper on Retina and anterior neural fold homeobox protein (RAX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retina and anterior neural fold homeobox protein (RAX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call